Health ❯ Healthcare ❯ Cancer

Immunotherapy

Pembrolizumab mRNA Vaccines Immune Checkpoint Inhibitors CAR-T Therapy Personalized Medicine Checkpoint Inhibitors Clinical Trials Atezolizumab Cancer Vaccines Drug Development

Personalized mRNA Vaccine Halves Five‑Year Melanoma Recurrence Risk

Five‑year results show durable drops in metastasis with higher survival, leaving phase 3 confirmation plus manufacturing scale‑up as remaining needs.

NHS England Rolls Out One-Minute Keytruda Jab for Cancer Care

Personalized mRNA Vaccine Shows Durable Survival Signal in Early Pancreatic Cancer

Revolution Medicines’ Pancreatic Cancer Drug Lands ASCO Plenary After Phase 3 Survival Gain

Ligand-Based OSM CAR-T Shows Preclinical Efficacy Against Osteosarcoma

BioNTech’s Personalized mRNA Vaccine Shows Durable Immune Response in Triple-Negative Breast Cancer Phase 1

Vaccimel, Argentina's Melanoma Immunotherapy, Enters Commercial Use

mRNA COVID Vaccines Linked to Longer Survival With Checkpoint Immunotherapy, Peer‑Reviewed Study Finds

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

Adjuvant Pembrolizumab Cuts Risk of Distant Metastases in Merkel Cell Carcinoma at ESMO 2025

NICE Approves Keytruda Combo for Advanced Endometrial Cancer on NHS

Meta-Analysis Shows 43% Overall Response for Fecal Transplants Combined with Cancer Immunotherapy

Phase 3 Trial Launches to Test Electric Field and Immunotherapy Combo in Glioblastoma

Camizestrant Cuts Breast Cancer Progression Risk by Over Half in Global Trial

Atezolizumab-Enhanced Chemotherapy Halves Recurrence in Stage III dMMR Colon Cancer

Study Finds NAD Decline Drives Age-Related CAR-T Cell Therapy Failures

Study Reveals Radiotherapy-Induced Protein Drives Tumor Metastasis

HSP-CAR30 Achieves Promising Results in Phase II Trial for Refractory Lymphomas

NHS Launches Fast-Track Trial for Personalized Melanoma Vaccine

First UK Patient Receives Promising Lung Cancer Vaccine